title: Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure.
abstract: Impaired endothelial-dependent vasodilation has been demonstrated in two animal models of congestive heart failure and in the coronary circulation of patients with idiopathic dilated cardiomyopathy. To determine whether this impairment contributes to the abnormal peripheral vasomotor tone in patients with congestive heart failure, the local vascular response to intraarterial infusions of graded concentrations (10(-8) M to 10(-5) M) of acetylcholine (an endothelial-dependent vasodilator) and nitroglycerin (a direct-acting vasodilator) was studied in the superficial femoral artery of 19 patients with congestive heart failure (New York Heart Association classes I to IV) and 6 age-matched normal control subjects. The local vascular response was determined from the arterial blood flow velocity pattern obtained by transcutaneous Doppler ultrasonography. Acetylcholine, 10(-5) M, induced a pattern characteristic of vasodilation in all six normal subjects; mean blood flow velocity for the group significantly increased from 11.9 +/- 2.7 to 44.8 +/- 20.9 cm/s (p less than 0.05). In contrast, the same dose of acetylcholine induced a blood flow velocity pattern characteristic of vasodilation in only 4 of the 19 patients with congestive heart failure. Group mean blood flow velocity did not change significantly. Nitroglycerin, 10(-7) M, induced vasodilation in all 6 normal subjects but in only 1 of 19 patients. Nitroglycerin, 10(-5) M, was administered to 10 patients; all 10 demonstrated a pattern characteristic of vasodilation. Thus, acetylcholine-mediated endothelial-dependent vasodilation appears to be impaired in the peripheral vasculature of patients with congestive heart failure. Both endothelial dysfunction and abnormal vascular smooth muscle responsiveness may contribute to abnormal peripheral vasomotor tone.
authors.affiliation: Department of Medicine, Albert Einstein College of Medicine, Bronx, New York 10461.
authors.forename: S D
authors.initials: SD
authors.lastname: Katz
authors.forename: L
authors.initials: L
authors.lastname: Biasucci
authors.forename: C
authors.initials: C
authors.lastname: Sabba
authors.forename: J A
authors.initials: JA
authors.lastname: Strom
authors.forename: G
authors.initials: G
authors.lastname: Jondeau
authors.forename: M
authors.initials: M
authors.lastname: Galvao
authors.forename: S
authors.initials: S
authors.lastname: Solomon
authors.forename: S D
authors.initials: SD
authors.lastname: Nikolic
authors.forename: R
authors.initials: R
authors.lastname: Forman
authors.forename: T H
authors.initials: TH
authors.lastname: LeJemtel
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D001783:Blood Flow Velocity / Q000187:drug effects; D002311:Cardiomyopathy, Dilated / Q000503:physiopathology; D002908:Chronic Disease; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology / Q000503:physiopathology*; D005260:Female; D005263:Femoral Artery / Q000000981:diagnostic imaging / Q000187:drug effects*; D006333:Heart Failure / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000494:pharmacology*; D014463:Ultrasonography; D014664:Vasodilation / Q000187:drug effects*
chemical_list: D005996:Nitroglycerin; D000109:Acetylcholine